Selskabets formål er at investere eller på anden måde være engageret i virksomheder, der beskæftiger sig med diagnostik og lægemiddeludvikling, herunder individualiseret medicin til kræftbehandling. Selskabet kan yde konsulent- og managementbistand til selskaber. The object of the company is to invest or otherwise be engaged in businesses that are involved in diagnostics and development of medicinal products, including individualized medicinal products for the treatment of cancer. The company may offer consultancy and management assistance to other companies.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | - | -393.8 mio. | 11.2 mio. | -198.8 mio. | 4 | |
CVR: 34623562
Secondary names: Oncology Venture Product Development ApS
Jeffrey Stuart Ervin joined as director
Alexander Epshinsky left as director
Companies in the same industry and area
CVR 38445928
CVR 29526346
CVR 37728403
CVR 40279865
CVR 63717916
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
companydata.dk